Symbol:
Epha3
Name:
Eph receptor A3
RGD ID:
68567
MGI Page
MGI
Description:
Enables ephrin receptor activity and growth factor binding activity. Involved in several processes, including axonal fasciculation; ephrin receptor signaling pathway; and synaptic membrane adhesion. Acts upstream of or within cellular response to follicle-stimulating hormone stimulus; negative regulation of neuron projection development; and regulation of cell migration. Is active in GABA-ergic synapse and presynapse. Is expressed in several structures, including alimentary system; embryo mesenchyme; genitourinary system; nervous system; and sensory organ. Human ortholog(s) of this gene implicated in pancreatic cancer. Orthologous to human EPHA3 (EPH receptor A3).
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
AW492086; Cek4; EK4; End; End3; EPH-like kinase 4; ephrin type-A receptor 3; ETK1; Hek; Hek4; Mek4; Tyr; Tyro4; tyrosine-protein kinase receptor ETK1; tyrosine-protein kinase TYRO4
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
EPHA3 (EPH receptor A3)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Rattus norvegicus (Norway rat):
Epha3 (Eph receptor A3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Epha3 (EPH receptor A3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
EPHA3 (EPH receptor A3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
EPHA3 (EPH receptor A3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Epha3 (EPH receptor A3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
EPHA3 (EPH receptor A3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
EPHA3 (EPH receptor A3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Epha3 (EPH receptor A3)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
EPHA7 (EPH receptor A7)
HGNC
OrthoMCL
Homo sapiens (human):
EPHA1 (EPH receptor A1)
HGNC
OrthoMCL
Homo sapiens (human):
EPHB3 (EPH receptor B3)
HGNC
OrthoMCL
Homo sapiens (human):
EPHB6 (EPH receptor B6)
HGNC
OrthoMCL
Homo sapiens (human):
EPHA2 (EPH receptor A2)
HGNC
OrthoMCL
Homo sapiens (human):
EPHA4 (EPH receptor A4)
HGNC
OrthoMCL
Homo sapiens (human):
EPHA10 (EPH receptor A10)
HGNC
OrthoMCL
Homo sapiens (human):
EPHA8 (EPH receptor A8)
HGNC
OrthoMCL
Homo sapiens (human):
EPHB1 (EPH receptor B1)
HGNC
OrthoMCL
Homo sapiens (human):
EPHB4 (EPH receptor B4)
HGNC
OrthoMCL
Homo sapiens (human):
EPHB2 (EPH receptor B2)
HGNC
OrthoMCL
Homo sapiens (human):
EPHA5 (EPH receptor A5)
HGNC
OrthoMCL
Homo sapiens (human):
EPHA6 (EPH receptor A6)
HGNC
OrthoMCL
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Epha3 (Eph receptor A3)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
EPHA3 (EPH receptor A3)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
epha3 (eph receptor A3)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid|ZFIN)
Drosophila melanogaster (fruit fly):
Eph
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
vab-1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
epha3
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|PANTHER|PhylomeDB)
Latest Assembly:
GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 16 63,363,895 - 63,684,538 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 16 63,363,897 - 63,684,538 (-) Ensembl GRCm39 Ensembl GRCm38 16 63,543,532 - 63,864,175 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 16 63,543,534 - 63,864,175 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 16 63,545,044 - 63,863,983 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 16 63,487,420 - 63,806,359 (-) NCBI MGSCv36 mm8 Celera 16 63,844,890 - 64,154,791 (-) NCBI Celera Cytogenetic Map 16 C1.3 NCBI cM Map 16 36.49 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Epha3 Mouse (-)-demecolcine decreases expression ISO RGD:68566 6480464 Demecolcine results in decreased expression of EPHA3 mRNA CTD PMID:23649840 Epha3 Mouse (S)-nicotine decreases expression ISO RGD:68566 6480464 Nicotine results in decreased expression of EPHA3 mRNA CTD PMID:18247414 Epha3 Mouse 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of EPHA3 mRNA CTD PMID:28960355 Epha3 Mouse 17beta-estradiol decreases expression ISO RGD:68566 6480464 Estradiol results in decreased expression of EPHA3 mRNA CTD PMID:21795739|PMID:31614463 Epha3 Mouse 17beta-estradiol multiple interactions ISO RGD:68566 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EPHA3 mRNA CTD PMID:20823114 Epha3 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:68389 6480464 Tetrachlorodibenzodioxin results in decreased expression of EPHA3 mRNA CTD PMID:32109520 Epha3 Mouse 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:68389 6480464 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of EPHA3 mRNA CTD PMID:32109520 Epha3 Mouse 2-naphthylamine decreases expression ISO RGD:68566 6480464 2-Naphthylamine results in decreased expression of EPHA3 mRNA CTD PMID:18247414 Epha3 Mouse acetamide decreases expression ISO RGD:68389 6480464 acetamide results in decreased expression of EPHA3 mRNA CTD PMID:31881176 Epha3 Mouse acrylamide decreases expression ISO RGD:68566 6480464 Acrylamide results in decreased expression of EPHA3 mRNA CTD PMID:32763439 Epha3 Mouse aldrin multiple interactions ISO RGD:68566 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated more ... CTD PMID:28263720 Epha3 Mouse all-trans-retinoic acid decreases expression ISO RGD:68566 6480464 Tretinoin results in decreased expression of EPHA3 mRNA CTD PMID:21934132 Epha3 Mouse allethrin multiple interactions ISO RGD:68389 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Epha3 Mouse alpha-amanitin affects expression EXP 6480464 Alpha-Amanitin affects the expression of EPHA3 mRNA CTD PMID:38531469 Epha3 Mouse ammonium chloride affects expression ISO RGD:68389 6480464 Ammonium Chloride affects the expression of EPHA3 mRNA CTD PMID:16483693 Epha3 Mouse antimycin A decreases expression ISO RGD:68566 6480464 Antimycin A results in decreased expression of EPHA3 mRNA CTD PMID:33512557 Epha3 Mouse aristolochic acid A decreases expression ISO RGD:68566 6480464 aristolochic acid I results in decreased expression of EPHA3 mRNA CTD PMID:33212167 Epha3 Mouse arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of EPHA3 mRNA CTD PMID:33053406 Epha3 Mouse atrazine affects methylation ISO RGD:68389 6480464 Atrazine affects the methylation of EPHA3 gene CTD PMID:35440735 Epha3 Mouse belinostat increases expression ISO RGD:68566 6480464 belinostat results in increased expression of EPHA3 mRNA CTD PMID:26272509 Epha3 Mouse benzo[a]pyrene decreases expression ISO RGD:68566 6480464 Benzo(a)pyrene results in decreased expression of EPHA3 mRNA CTD PMID:18247414 Epha3 Mouse bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:68389 6480464 [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of EPHA3 mRNA CTD PMID:25031359 Epha3 Mouse bisphenol A decreases expression ISO RGD:68389 6480464 bisphenol A results in decreased expression of EPHA3 mRNA CTD PMID:25181051 Epha3 Mouse bucladesine multiple interactions ISO RGD:68566 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EPHA3 mRNA CTD PMID:20823114 Epha3 Mouse cadmium atom decreases expression ISO RGD:68566 6480464 Cadmium results in decreased expression of EPHA3 mRNA CTD PMID:33559965 Epha3 Mouse cadmium dichloride increases methylation ISO RGD:68389 6480464 Cadmium Chloride results in increased methylation of EPHA3 promoter CTD PMID:22457795 Epha3 Mouse cadmium dichloride increases expression ISO RGD:68389 6480464 Cadmium Chloride results in increased expression of EPHA3 mRNA CTD PMID:33453195 Epha3 Mouse cocaine affects expression ISO RGD:68389 6480464 Cocaine affects the expression of EPHA3 mRNA CTD PMID:15691709 Epha3 Mouse cyhalothrin multiple interactions ISO RGD:68389 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Epha3 Mouse cypermethrin multiple interactions ISO RGD:68389 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Epha3 Mouse DDD multiple interactions ISO RGD:68566 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated more ... CTD PMID:28263720 Epha3 Mouse DDE multiple interactions ISO RGD:68566 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated more ... CTD PMID:28263720 Epha3 Mouse DDT multiple interactions ISO RGD:68566 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated more ... CTD PMID:28263720 Epha3 Mouse dibutyl phthalate decreases expression ISO RGD:68389 6480464 Dibutyl Phthalate results in decreased expression of EPHA3 mRNA CTD PMID:21266533 Epha3 Mouse dieldrin multiple interactions ISO RGD:68566 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated more ... CTD PMID:28263720 Epha3 Mouse dioxygen increases expression ISO RGD:68566 6480464 Oxygen deficiency results in increased expression of EPHA3 mRNA CTD PMID:24236059 Epha3 Mouse diquat decreases expression EXP 6480464 Diquat results in decreased expression of EPHA3 mRNA CTD PMID:36851058 Epha3 Mouse dorsomorphin multiple interactions ISO RGD:68566 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Epha3 Mouse doxorubicin increases expression ISO RGD:68566 6480464 Doxorubicin results in increased expression of EPHA3 mRNA CTD PMID:30031762 Epha3 Mouse doxorubicin decreases expression ISO RGD:68566 6480464 Doxorubicin results in decreased expression of EPHA3 mRNA CTD PMID:29803840 Epha3 Mouse endosulfan decreases expression ISO RGD:68389 6480464 Endosulfan results in decreased expression of EPHA3 mRNA CTD PMID:29391264 Epha3 Mouse endrin multiple interactions ISO RGD:68566 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated more ... CTD PMID:28263720 Epha3 Mouse entinostat decreases expression ISO RGD:68566 6480464 entinostat results in decreased expression of EPHA3 mRNA CTD PMID:27188386 Epha3 Mouse ethyl methanesulfonate decreases expression ISO RGD:68566 6480464 Ethyl Methanesulfonate results in decreased expression of EPHA3 mRNA CTD PMID:23649840 Epha3 Mouse fenvalerate multiple interactions ISO RGD:68389 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in more ... CTD PMID:34896426 Epha3 Mouse folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of EPHA3 mRNA CTD PMID:25629700 Epha3 Mouse formaldehyde decreases expression ISO RGD:68566 6480464 Formaldehyde results in decreased expression of EPHA3 mRNA CTD PMID:23649840 Epha3 Mouse furan increases expression ISO RGD:68389 6480464 furan results in increased expression of EPHA3 mRNA CTD PMID:26194646 Epha3 Mouse gamma-hexachlorocyclohexane multiple interactions ISO RGD:68566 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated more ... CTD PMID:28263720 Epha3 Mouse genistein multiple interactions ISO RGD:68389 6480464 [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of EPHA3 mRNA; [Genistein co-treated with more ... CTD PMID:21782745|PMID:25031359 Epha3 Mouse genistein increases expression EXP 6480464 Genistein results in increased expression of EPHA3 mRNA CTD PMID:32186404 Epha3 Mouse Licochalcone B decreases expression ISO RGD:68566 6480464 licochalcone B results in decreased expression of EPHA3 mRNA CTD PMID:33647349 Epha3 Mouse lipopolysaccharide multiple interactions ISO RGD:68566 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EPHA3 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... CTD PMID:35811015 Epha3 Mouse medroxyprogesterone acetate multiple interactions ISO RGD:68566 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EPHA3 mRNA CTD PMID:20823114 Epha3 Mouse methoxychlor multiple interactions ISO RGD:68389 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of EPHA3 mRNA CTD PMID:21782745 Epha3 Mouse methyl methanesulfonate decreases expression ISO RGD:68566 6480464 Methyl Methanesulfonate results in decreased expression of EPHA3 mRNA CTD PMID:23649840 Epha3 Mouse methylmercury chloride decreases expression ISO RGD:68566 6480464 methylmercuric chloride results in decreased expression of EPHA3 mRNA CTD PMID:28001369 Epha3 Mouse N,N-diethyl-m-toluamide multiple interactions ISO RGD:68389 6480464 [Permethrin co-treated with DEET] results in decreased methylation of EPHA3 gene CTD PMID:33148267 Epha3 Mouse N-methyl-4-phenylpyridinium decreases expression ISO RGD:68566 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of EPHA3 mRNA CTD PMID:24810058 Epha3 Mouse nicotine decreases expression ISO RGD:68566 6480464 Nicotine results in decreased expression of EPHA3 mRNA CTD PMID:18247414 Epha3 Mouse okadaic acid decreases expression ISO RGD:68566 6480464 Okadaic Acid results in decreased expression of EPHA3 mRNA CTD PMID:38832940 Epha3 Mouse ozone decreases expression ISO RGD:68389 6480464 Ozone results in decreased expression of EPHA3 mRNA CTD PMID:16330353 Epha3 Mouse panobinostat multiple interactions ISO RGD:68566 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Epha3 Mouse panobinostat increases expression ISO RGD:68566 6480464 panobinostat results in increased expression of EPHA3 mRNA CTD PMID:26272509 Epha3 Mouse permethrin multiple interactions ISO RGD:68389 6480464 [Permethrin co-treated with DEET] results in decreased methylation of EPHA3 gene CTD PMID:33148267 Epha3 Mouse phenylmercury acetate increases expression ISO RGD:68566 6480464 Phenylmercuric Acetate results in increased expression of EPHA3 mRNA CTD PMID:26272509 Epha3 Mouse phenylmercury acetate multiple interactions ISO RGD:68566 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Epha3 Mouse picoxystrobin decreases expression ISO RGD:68566 6480464 picoxystrobin results in decreased expression of EPHA3 mRNA CTD PMID:33512557 Epha3 Mouse pioglitazone multiple interactions EXP 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of EPHA3 mRNA CTD PMID:27935865 Epha3 Mouse ponatinib decreases activity ISO RGD:68566 6480464 ponatinib analog results in decreased activity of EPHA3 protein; ponatinib results in decreased activity of more ... CTD PMID:19878872|PMID:21561767 Epha3 Mouse potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of EPHA3 mRNA CTD PMID:23608068 Epha3 Mouse progesterone increases expression ISO RGD:68566 6480464 Progesterone results in increased expression of EPHA3 mRNA CTD PMID:21795739 Epha3 Mouse pyrethrins decreases expression ISO RGD:68389 6480464 Pyrethrins results in decreased expression of EPHA3 protein CTD PMID:34896426 Epha3 Mouse rofecoxib decreases expression ISO RGD:68566 6480464 rofecoxib results in decreased expression of EPHA3 mRNA CTD PMID:17070997 Epha3 Mouse rotenone increases expression ISO RGD:68566 6480464 Rotenone results in increased expression of EPHA3 mRNA CTD PMID:36586010 Epha3 Mouse S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:68566 6480464 S-(1,2-dichlorovinyl)cysteine results in decreased expression of EPHA3 mRNA CTD PMID:35811015 Epha3 Mouse S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:68566 6480464 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EPHA3 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... CTD PMID:35811015 Epha3 Mouse SB 431542 multiple interactions ISO RGD:68566 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression more ... CTD PMID:27188386 Epha3 Mouse silicon dioxide decreases expression ISO RGD:68389 6480464 Silicon Dioxide results in decreased expression of EPHA3 mRNA CTD PMID:32721576 Epha3 Mouse silver atom decreases expression EXP 6480464 Silver results in decreased expression of EPHA3 mRNA CTD PMID:27131904 Epha3 Mouse silver(0) decreases expression EXP 6480464 Silver results in decreased expression of EPHA3 mRNA CTD PMID:27131904 Epha3 Mouse simvastatin multiple interactions ISO RGD:68566 6480464 [Hexachlorocyclohexane co-treated with Aldrin co-treated with Dieldrin co-treated with Endrin co-treated with Dichlorodiphenyl Dichloroethylene co-treated more ... CTD PMID:28263720 Epha3 Mouse sotorasib multiple interactions ISO RGD:68566 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EPHA3 mRNA CTD PMID:36139627 Epha3 Mouse sunitinib increases expression ISO RGD:68566 6480464 Sunitinib results in increased expression of EPHA3 mRNA CTD PMID:31533062 Epha3 Mouse temozolomide increases expression ISO RGD:68566 6480464 Temozolomide results in increased expression of EPHA3 mRNA CTD PMID:31758290 Epha3 Mouse tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of EPHA3 mRNA CTD PMID:28973375 Epha3 Mouse tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of EPHA3 mRNA CTD PMID:17484886 Epha3 Mouse titanium dioxide decreases methylation EXP 6480464 titanium dioxide results in decreased methylation of EPHA3 gene CTD PMID:35295148 Epha3 Mouse trametinib multiple interactions ISO RGD:68566 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EPHA3 mRNA CTD PMID:36139627 Epha3 Mouse trichostatin A decreases expression ISO RGD:68566 6480464 trichostatin A results in decreased expression of EPHA3 mRNA CTD PMID:24935251|PMID:26272509|PMID:26705709 Epha3 Mouse trichostatin A multiple interactions ISO RGD:68566 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Epha3 Mouse triclosan increases expression ISO RGD:68566 6480464 Triclosan results in increased expression of EPHA3 mRNA CTD PMID:30510588 Epha3 Mouse valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of EPHA3 mRNA CTD PMID:17292431 Epha3 Mouse valproic acid decreases expression ISO RGD:68566 6480464 Valproic Acid results in decreased expression of EPHA3 mRNA CTD PMID:23179753|PMID:27188386 Epha3 Mouse valproic acid increases expression ISO RGD:68566 6480464 Valproic Acid results in increased expression of EPHA3 mRNA CTD PMID:23179753|PMID:24935251|PMID:28001369 Epha3 Mouse XL147 multiple interactions EXP 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPHA3 mRNA CTD PMID:27935865
Imported Annotations - PID (archival)
(-)-demecolcine (ISO) (S)-nicotine (ISO) 1,2-dichloroethane (EXP) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 2,3,7,8-Tetrachlorodibenzofuran (ISO) 2-naphthylamine (ISO) acetamide (ISO) acrylamide (ISO) aldrin (ISO) all-trans-retinoic acid (ISO) allethrin (ISO) alpha-amanitin (EXP) ammonium chloride (ISO) antimycin A (ISO) aristolochic acid A (ISO) arsenite(3-) (EXP) atrazine (ISO) belinostat (ISO) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (ISO) bucladesine (ISO) cadmium atom (ISO) cadmium dichloride (ISO) cocaine (ISO) cyhalothrin (ISO) cypermethrin (ISO) DDD (ISO) DDE (ISO) DDT (ISO) dibutyl phthalate (ISO) dieldrin (ISO) dioxygen (ISO) diquat (EXP) dorsomorphin (ISO) doxorubicin (ISO) endosulfan (ISO) endrin (ISO) entinostat (ISO) ethyl methanesulfonate (ISO) fenvalerate (ISO) folic acid (EXP) formaldehyde (ISO) furan (ISO) gamma-hexachlorocyclohexane (ISO) genistein (EXP,ISO) Licochalcone B (ISO) lipopolysaccharide (ISO) medroxyprogesterone acetate (ISO) methoxychlor (ISO) methyl methanesulfonate (ISO) methylmercury chloride (ISO) N,N-diethyl-m-toluamide (ISO) N-methyl-4-phenylpyridinium (ISO) nicotine (ISO) okadaic acid (ISO) ozone (ISO) panobinostat (ISO) permethrin (ISO) phenylmercury acetate (ISO) picoxystrobin (ISO) pioglitazone (EXP) ponatinib (ISO) potassium dichromate (EXP) progesterone (ISO) pyrethrins (ISO) rofecoxib (ISO) rotenone (ISO) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) silicon dioxide (ISO) silver atom (EXP) silver(0) (EXP) simvastatin (ISO) sotorasib (ISO) sunitinib (ISO) temozolomide (ISO) tetrachloroethene (EXP) tetrachloromethane (EXP) titanium dioxide (EXP) trametinib (ISO) trichostatin A (ISO) triclosan (ISO) valproic acid (EXP,ISO) XL147 (EXP)
1.
Zic2 controls cerebellar development in cooperation with Zic1.
Aruga J, etal., J Neurosci 2002 Jan 1;22(1):218-25.
2.
Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors.
Cheng N, etal., Neoplasia. 2003 Sep-Oct;5(5):445-56.
3.
Upregulation of EphA3 receptor after spinal cord injury.
Irizarry-Ramirez M, etal., J Neurotrauma. 2005 Aug;22(8):929-35.
4.
Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.
Ivanov AI, etal., Physiol Genomics. 2005 Apr 14;21(2):152-60. Epub 2005 Jan 25.
5.
Electronic Transfer of Homolog Data
MGD and Homologene mouse data transfer
6.
MGDs mouse GO annotations
MGD data from the GO Consortium
7.
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.
Okazaki Y, etal., Nature. 2002 Dec 5;420(6915):563-73.
8.
PID Annotation Import Pipeline
Pipeline to import Pathway Interaction Database annotations from NCI into RGD
9.
Mouse MP Annotation Import Pipeline
RGD automated import pipeline
10.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
11.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
Epha3 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 16 63,363,895 - 63,684,538 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 16 63,363,897 - 63,684,538 (-) Ensembl GRCm39 Ensembl GRCm38 16 63,543,532 - 63,864,175 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 16 63,543,534 - 63,864,175 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 16 63,545,044 - 63,863,983 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 16 63,487,420 - 63,806,359 (-) NCBI MGSCv36 mm8 Celera 16 63,844,890 - 64,154,791 (-) NCBI Celera Cytogenetic Map 16 C1.3 NCBI cM Map 16 36.49 NCBI
EPHA3 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 3 89,107,621 - 89,482,134 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 3 89,107,621 - 89,482,134 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 3 89,156,771 - 89,531,284 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 3 89,239,364 - 89,613,974 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 3 89,239,501 - 89,532,185 NCBI Celera 3 89,910,744 - 90,285,017 (+) NCBI Celera Cytogenetic Map 3 p11.1 NCBI HuRef 3 89,169,906 - 89,544,877 (+) NCBI HuRef CHM1_1 3 89,109,505 - 89,484,203 (+) NCBI CHM1_1 T2T-CHM13v2.0 3 89,183,660 - 89,558,507 (+) NCBI T2T-CHM13v2.0
Epha3 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 11 14,585,041 - 14,920,721 (-) NCBI GRCr8 mRatBN7.2 11 1,138,485 - 1,474,102 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 11 1,140,985 - 1,473,900 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 11 9,737,055 - 10,069,925 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 11 2,530,362 - 2,863,260 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 11 1,635,123 - 1,968,001 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 11 421,253 - 783,037 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 11 421,135 - 782,954 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 11 420,518 - 782,868 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 11 696,185 - 1,033,287 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 11 696,200 - 1,033,287 (-) NCBI Celera 11 1,134,161 - 1,466,533 (-) NCBI Celera Cytogenetic Map 11 p12 NCBI
Epha3 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955407 4,138,362 - 4,500,688 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955407 4,135,671 - 4,500,900 (-) NCBI ChiLan1.0 ChiLan1.0
EPHA3 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 2 89,283,121 - 89,651,438 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 3 89,287,895 - 89,656,226 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 3 89,261,166 - 89,629,010 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 3 91,369,233 - 91,737,300 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 3 91,369,239 - 91,739,056 (+) Ensembl panpan1.1 panPan2
EPHA3 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 33 770,234 - 1,092,063 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 33 769,423 - 1,115,986 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 33 949,355 - 1,298,894 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 33 810,080 - 1,159,494 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 33 810,033 - 1,149,524 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 33 779,847 - 1,129,604 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 33 811,416 - 1,161,165 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 33 1,284,819 - 1,381,967 (+) NCBI UU_Cfam_GSD_1.0
Epha3 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
EPHA3 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 13 166,592,493 - 166,942,767 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 13 166,592,492 - 166,942,791 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 13 177,406,602 - 177,539,843 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3 Sscrofa10.2 13 177,670,369 - 177,810,115 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
EPHA3 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 22 87,480,220 - 87,840,628 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 22 87,480,126 - 87,838,512 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666041 78,860,955 - 79,218,698 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Epha3 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 896 Count of miRNA genes: 486 Interacting mature miRNAs: 633 Transcripts: ENSMUST00000064405 Prediction methods: Miranda, Targetscan Result types: miRGate_prediction
1301138 Pcd4ts3_m p-glycoprotein positive CD4 T cell subset 3 (mouse) Not determined 16 40593923 74594076 Mouse 1301394 Eae11_m susceptibility to experimental allergic encephalomyelitis 11 (mouse) Not determined 16 53561891 87562035 Mouse 26884376 Skwq4_m skull length QTL 4, 5 week (mouse) 16 8417864 90896888 Mouse 1302096 Aod1a_m autoimmune ovarian dysgenesis 1a (mouse) Not determined 16 35446643 92573008 Mouse 4141212 Imraq3_m immune response to AAV2 QTL 3 (mouse) Not determined 16 44383350 78383506 Mouse 1558836 Dice1b_m determination of interleukin 4 commitment 1b (mouse) Not determined 16 45511000 72274485 Mouse 1558740 Bpq9_m blood pressure QTL 9 (mouse) Not determined 16 63327336 97327472 Mouse 1301719 Remslp3_m rapid eye movement sleep 3 (mouse) Not determined 16 44383350 78383506 Mouse 1357778 Diobq_m diet-induced obesity QTL (mouse) Not determined 16 42197817 82331174 Mouse 4141113 Tgq28_m triglyceride QTL 28 (mouse) Not determined 62986646 96986646 Mouse 1301364 Lith14_m lithogenic gene 14 (mouse) Not determined 16 55661846 89661961 Mouse 26884432 Zlq7_m zygomatic length QTL 7, 10 week (mouse) 16 3817864 64620363 Mouse 1300928 Etia_m ethanol induced activation (mouse) Not determined 16 63313907 97314016 Mouse 4142187 Arrd3_m age-related retinal degeneration 3 (mouse) Not determined 32522909 65466552 Mouse 11522747 Eae41_m experimental allergic encephalomyelitis susceptibility 41 (mouse) 16 40399134 78015472 Mouse 14928310 Manh80_m mandible shape 80 (mouse) 16 48219841 82219841 Mouse 1301125 Sluc27_m susceptibility to lung cancer 27 (mouse) Not determined 16 61608644 95608764 Mouse 1357763 Lp1_m lymphocyte proliferation 1 (mouse) Not determined 16 6542979 65466552 Mouse 1357517 Bwtn1_m body weight at necropsy 1 (mouse) Not determined 16 20019329 85600826 Mouse 26884416 Bzwq5_m bi-zygomatic width QTL 5, 5 week (mouse) 16 37320362 84696888 Mouse 1301070 Cypr1_m cytokine production 1 (mouse) Not determined 16 32312795 66312933 Mouse 27226785 Feml12_m femur length 12, 5 week (mouse) 16 3317864 64620363 Mouse 4142112 Skts-fp3_m skin tumor susceptibility in FVB and PWK 3 (mouse) Not determined 16 40053881 72924385 Mouse
AW492086
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 16 63,603,529 - 63,603,622 UniSTS GRCm38 MGSCv37 16 63,603,355 - 63,603,448 UniSTS GRCm37 Celera 16 63,902,969 - 63,903,062 UniSTS Cytogenetic Map 16 C1.3 UniSTS Whitehead/MRC_RH 16 704.16 UniSTS
Epha3
Mouse Assembly Chr Position (strand) Source JBrowse MGSCv37 16 63,566,410 - 63,566,476 UniSTS GRCm37 MGSCv37 16 63,863,882 - 63,863,945 UniSTS GRCm37 MGSCv37 16 63,545,830 - 63,545,975 UniSTS GRCm37 Celera 16 63,845,676 - 63,845,821 UniSTS Celera 16 63,866,112 - 63,866,178 UniSTS Celera 16 64,154,690 - 64,154,753 UniSTS Cytogenetic Map 16 C1.3 UniSTS cM Map 16 UniSTS
M68513
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 16 63,545,997 - 63,546,131 UniSTS GRCm38 MGSCv37 16 63,545,823 - 63,545,957 UniSTS GRCm37 Celera 16 63,845,669 - 63,845,803 UniSTS Cytogenetic Map 16 C1.3 UniSTS Whitehead/MRC_RH 16 706.12 UniSTS
UniSTS:224333
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 16 63,610,631 - 63,610,786 UniSTS GRCm38 MGSCv37 16 63,610,457 - 63,610,612 UniSTS GRCm37 Celera 16 63,910,067 - 63,910,222 UniSTS Cytogenetic Map 16 C1.3 UniSTS
Epha3
Mouse Assembly Chr Position (strand) Source JBrowse Cytogenetic Map 16 C1.3 UniSTS
Epha3
Mouse Assembly Chr Position (strand) Source JBrowse Cytogenetic Map 16 C1.3 UniSTS
Epha3
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 16 63,566,584 - 63,566,650 UniSTS GRCm38 MGSCv37 16 63,566,410 - 63,566,476 UniSTS GRCm37 Celera 16 63,866,112 - 63,866,178 UniSTS Cytogenetic Map 16 C1.3 UniSTS
Epha3
Mouse Assembly Chr Position (strand) Source JBrowse Cytogenetic Map 16 C1.3 UniSTS
Epha3
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 16 63,864,056 - 63,864,119 UniSTS GRCm38 MGSCv37 16 63,863,882 - 63,863,945 UniSTS GRCm37 Celera 16 64,154,690 - 64,154,753 UniSTS Cytogenetic Map 16 C1.3 UniSTS
Epha3
Mouse Assembly Chr Position (strand) Source JBrowse GRCm38 16 63,546,004 - 63,546,149 UniSTS GRCm38 MGSCv37 16 63,545,830 - 63,545,975 UniSTS GRCm37 Celera 16 63,845,676 - 63,845,821 UniSTS Cytogenetic Map 16 C1.3 UniSTS cM Map 16 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
Ensembl Acc Id:
ENSMUST00000064405 ⟹ ENSMUSP00000066554
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 16 63,363,897 - 63,684,521 (-) Ensembl GRCm38.p6 Ensembl 16 63,543,534 - 63,864,158 (-) Ensembl
Ensembl Acc Id:
ENSMUST00000231270 ⟹ ENSMUSP00000156331
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 16 63,593,564 - 63,684,499 (-) Ensembl GRCm38.p6 Ensembl 16 63,773,201 - 63,864,136 (-) Ensembl
Ensembl Acc Id:
ENSMUST00000232049 ⟹ ENSMUSP00000155946
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 16 63,366,468 - 63,684,443 (-) Ensembl GRCm38.p6 Ensembl 16 63,546,105 - 63,864,080 (-) Ensembl
Ensembl Acc Id:
ENSMUST00000232370
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 16 63,662,281 - 63,684,538 (-) Ensembl GRCm38.p6 Ensembl 16 63,841,918 - 63,864,175 (-) Ensembl
Ensembl Acc Id:
ENSMUST00000232461 ⟹ ENSMUSP00000155890
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 16 63,431,386 - 63,683,776 (-) Ensembl GRCm38.p6 Ensembl 16 63,611,023 - 63,863,413 (-) Ensembl
Ensembl Acc Id:
ENSMUST00000232654 ⟹ ENSMUSP00000155997
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 Ensembl 16 63,430,675 - 63,684,520 (-) Ensembl GRCm38.p6 Ensembl 16 63,610,312 - 63,864,157 (-) Ensembl
RefSeq Acc Id:
NM_001362452 ⟹ NP_001349381
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 16 63,363,895 - 63,684,538 (-) NCBI GRCm38 16 63,543,532 - 63,864,175 (-) NCBI
Sequence:
AGTGTCAAACTTGACATCAGACTGCGAGCGGAGCATGGTAACTTCTCCAGCAATCAGAGCGCTCCCCCTCACATCAGTGGTATGCTTCGCGGAGATATGCTCCTCTCACTGCCCGGTGCACCAGCAAC ATGGATTGTCACCTCTCCATCCTCGTCCTGCTCGGCTGCTGCGTCCTCAGCTGCTCCGGAGAACTGAGCCCACAGCCTTCCAACGAAGTTAATCTACTAGATTCGAAAACAATTCAAGGAGAGCTGGG CTGGATCTCCTACCCATCCCATGGGTGGGAAGAGATCAGTGGTGTTGATGAACATTACACACCAATCAGGACTTACCAGGTGTGCAATGTCATGGATCACAGCCAAAATAATTGGCTGAGGACAAACT GGGTACCCAGAAACTCAGCTCAGAAGATCTATGTGGAGCTAAAGTTCACACTGCGGGACTGTAACAGCATTCCATTGGTTTTGGGGACTTGCAAGGAGACCTTTAACCTGTACTACATGGAGTCTGAT GATGATCATGGCGTCAAATTCCGAGAGCATCAGTTCACGAAGATTGACACCATTGCCGCTGATGAAAGTTTCACTCAGATGGATCTCGGGGATCGCATTCTGAAACTCAACACTGAGATTAGAGAAGT GGGACCAGTCAACAAAAAGGGGTTTTATTTGGCCTTTCAAGATGTTGGTGCTTGTGTTGCCTTGGTGTCTGTGAGAGTGTACTTCAAAAAGTGCCCGTTTACAGTGAAGAATCTGGCTATGTTTCCAG ACACAGTGCCCATGGACTCCCAGTCTTTGGTGGAGGTTAGGGGCTCTTGTGTCAATAATTCCAAAGAGGAGGACCCTCCCAGGATGTACTGCAGCACAGAAGGGGAATGGCTGGTCCCCATTGGCAAA TGCACTTGCAATGCTGGGTATGAAGAACGAGGTTTCATATGCCAAGCTTGTCGACCAGGCTTCTACAAGGCTTCCGATGGTGCTGCTAAGTGTGCTAAGTGCCCACCACACAGCTCAACACAAGAAGA TGGTTCAATGAACTGCAGGTGTGAGAATAATTATTTCCGGGCAGAAAAAGACCCTCCATCCATGGCTTGTACCCGACCTCCATCCGCACCAAGAAATGTTATCTCAAACATAAACGAGACCTCGGTTA TCCTGGACTGGAGTTGGCCCCTGGACACAGGAGGCCGGAAGGATATTACCTTCAACATCATATGTAAAAAGTGTGGGTGGAATGTCAGGCAGTGTGAGCCGTGCAGCCCCAACGTCCGCTTCCTTCCT CGGCAGCTTGGACTCACCAACACCACGGTGACAGTGACAGACCTCCTAGCTCACACCAACTACACCTTTGAGATCGATGCTGTTAATGGGGTGTCAGAGCTGAGCTCGCCACCGAGACAGTATGCCGC AGTCAGCATCACAACTAATCAGGCTGCTCCATCACCAGTTATGACAATTAAGAAAGATCGGACTTCCAGAAACAGTATCTCTTTATCTTGGCAAGAACCGGAACATCCAAATGGAATTATCCTGGACT ATGAGGTCAAATACTATGAAAAGGAGCAAGAGACGAGTTATACCATTTTGAGAGCAAGAGGCACAAATGTTACTATCAGTAGCCTCAAGCCAGATACTACTTATGTCTTCCAAATCCGAGCTCGGACA GCAGCGGGATATGGAACCAACAGCCGCAAATTTGAATTTGAAACTAGCCCAGACTCTTTCTCCATCTCCGGTGAAAACAGTCATGTGGTGATGATTGCTATTTCCGCAGCTGTGGCCATCATTGTCCT CACGGTGGTCACCTATGTTCTGGTCGGGAGGTTTTGTGGCTATCACAAGTCAAAACACAGTGCAGAGGAGAAGCGCCTTCACTTTGGGAATGGCCACTTAAAACTTCCAGGTCTCAGGACCTATGTTG ATCCACATACATATGAAGACCCTACTCAAGCAGTTCATGAGTTCGCGAAGGAGTTGGATGCCACCAATATATCCATCGACAAAGTTGTTGGAGCAGGTGAATTTGGAGAAGTTTGCAGCGGCCGCTTA AAACTTCCTTCAAAAAAAGAGATTTCGGTGGCCATAAAGACCCTGAAAGTAGGGTATACCGAGAAACAGAGGAGAGACTTCCTCGGTGAAGCGAGCATCATGGGACAGTTTGACCATCCCAACATCAT CCGACTGGAAGGCGTTGTCACTAAGAGTAAGCCAGTGATGATTGTCACGGAATACATGGAGAATGGCTCCTTGGACAGTTTCTTACGTAAGCACGATGCCCAGTTCACAGTCATCCAGCTTGTGGGAA TGCTCCGTGGGATAGCATCAGGTATGAAATACCTCTCAGATATGGGCTACGTCCACCGGGACCTTGCTGCTCGCAACATCTTGATCAACAGTAACTTAGTGTGTAAAGTTTCTGACTTTGGACTCTCT CGGGTACTTGAAGATGACCCAGAAGCTGCTTACACAACCAGGGGAGGAAAGATACCAATAAGGTGGACATCACCAGAAGCAATTGCCTACCGCAAGTTCACCTCAGCCAGCGATGTATGGAGTTACGG GATTGTTCTCTGGGAAGTGATGTCTTACGGAGAAAGGCCATACTGGGAGATGTCCAATCAGGATGTAATTAAGGCTGTGGATGAGGGCTATCGCCTGCCACCTCCCATGGATTGCCCAGCTGCCTTGT ATCAGTTGATGTTGGACTGCTGGCAGAAAGACAGGAACAACAGACCCAAGTTCGAGCAGATCGTCAGCATTCTGGACAAACTCATCCGGAATCCAGGCAGTCTGAAGATCATCACCAGCGCGGCTGCA AGGCCATCAAACCTTCTTCTGGACCAAAGCAATGTCGATATCGCTACCTTCCACACAACTGGTGATTGGCTTAACGGCATGAGGACAGCACACTGTAAGGAAATCTTCACAGGCGTCGAATACAGCTC CTGTGACACCATTGCCAAGATCTCCACAGATGACATGAAAAAGGTTGGTGTCACTGTGGTTGGGCCACAGAAGAAGATCATCAGCACCATTAAAGCTCTAGAAACACAATCTAAGAATGGTCCAGTTC CAGTGTAAAGTCCTGGAGGGATGTGAGAAACGGGAAGATGCAGCAGCATCCTGCAGACAGATGGAAATGATAAATAAGATGCTGCAGAAAGCTCCAAGTCTAATAAGACACTCAGTTATAAGTCCAAA TGCCTTAAAATGGAATTGAAAAATCTCTTTATTTTCCCCTATCATTTTACAGATGGGTGGGTGGGTGCATTTTGCTTTGTAATTGCTTTTTAAATGTTAATTGATGGGGTTAGTTAAAATTCTTCAGT ATGAAGTGGAAGAACTAGTGTAGAGCCATTGATCATTAACTATCATGGAAATAAACCAAGTAAACTAGCAAAACAGACCTGAAGGCTTTGTTGTGAATGGCCACAGAGGAAAAGACTTGTCGTATTTT TATACACAGAAAAAAATCTGTAACAGGTATTTTGTTTCTTTTAAAAACAAGCAAAATGGAGGCATTTATACCTCAAACTATCTGGCCATACTTACTACCTTATCACGTTAGTATTCTCTTTATCTGTT TGAAGCATATAGAGATAAAGTTTGTAGTTGTTTTAAATACTATACATTTTTAATTGTTACCTTCCTTAAGTAGACCATGTAAAAACACGTCTTAATTTGGGGGCAAGTGCGTATTTATTTTCTTTTGG ATTTTTAAATTGTTTTATATTTATGCCTTGATGATTTAATTTGGGTTTTGTTACAGCCAAGTGCCAAATGCTATTGCAAATTGTCAGCAGTAAGAAACATGTTTAACTATACCCAGAGAATTATATGT TCTTTTCTACAACTGTTGAACAATCCACTTACATGTACCAACAAAATGAAATGCTTTCCCTGTTCCTACTGTCACCAAATCACTCACAGTCTGAATATCCCATTCATTTTTGTCTCTTCATTTATCAG TAAATGTATGCTCCTAATTTAGTGTAATATACTGGCTTGTATGTAATAGATTTTTACCAAGATGTCATACCTTCCCTACTCTGGTGCTTAGAGGATATCAACTCCTTTCATTCATGAAAGAAGCTTGT TAGAACTCCTTAGATTTGCAAACTGGAAAGATCAAAATGAGGTTAAATGGTTACAGTAATTGACAGCAGCATATAGGTAAATGCATGAGCCAAAAAAAAAAAAAATGATAAGAAAGAAAAATTGCTTG TTTTGAAAAGTCTTAATATCATTGCTTAAACATGTAGAGAATGATGATAACTAAGCTACTCATCTGCATCACTGGGGTGTACGTCAATTAATTGCACACTTTCATGATCAATATCAGGTATAACTATC TTTGAGTCTTCCACTTCAATGTACCTATTGTGAGTTAGGTGCATGATTAGAAGCCTTGGCCTTCTAAACATATTATTAAGCATAACATTTTTGAAAAAGCAACTCATCGAACCAATAAATCCACATCC ACAGACAATGGAGGAATGAGATGTCTCATTATGGGGATGTAGTCTTGCTGTTCCGGAAAGGCCAATTGTAAGCATATTCTTGAATATTAAGAAGGATGTGCCTAACGGGCATCCTGATGATGACACAT GCTGAAGCAATATTTTAGATTCTGGATTTTCTTGCTGATAGTATCATTCCATAGGATCAAGGGATGTGTGTGTCACAGAACAAGATGGTTCAAACAGTGCTGTACGAAATACGTCTCTATGCAAAAAG GGACACTAAAGAAATACAGCTTCCAATCATAGAGGCAGATTTCCAAATGTAATCTGTTGTAGGTTTAGTATACTAGAGCTTAGGTGAGTTCTTTCAGATGTGAAATTGTTTCCCAAATGTTGACAATA CTCCGTATCATGCTGCTAGAATTTGTACTGAACTTATAAGAGCATGAATATTTTGGAAATGAGCTGATGAAACTAATAATAAATTTTATATGTCCTGAAAGCAGGTAGAAAAGACTCTAATCAAGTAA TTTAAAATTTGGAATACCAGGTCAAAATTCAAATCCAGCATCTGAACCAATTCGCCTATGACAGCATTGATTCTCTTAGGCAATATTCTGAACATGCTAAAAAAATGAATTTCAAAATAATTAGGTAT TCAAAACTTGTTGAATCTGTTGCATTTATTTTGACTGAGAATTTTGTTTGAAATTAGAGGTGGTTTAAGCAGTATATTGCTTTTCATTTGTCAGTATTTTTCTATCTCACCGTTTATGGATTTCCTTT GCATAACCCCTTCCCTGTACATATGTAAACATAACAGTGTACGATTCTGGACTGGGGAGTAGAGGTACTAGATCGCTTATGGCCATCTCTTTGTACAGGAACTACATTGCCTTCCCATATCAATGAGG CTACCGCTCCCTTGCCATGTTATGTACCATATTACCTGATTTGTATCTTAAATTTGATTTATAGATATTATTTATTTCTCGCAACACACCCAGTCTAGGCTGTACTGAGTATCTATCAAGCCATGTAT AAATATGATATGATTGGCAGTATGTGTTTACTTTAAACTTGCATTTTAAAAACATGGTTCATTTAGTTTATGTTGCACAATGTAGATGGCCTCTTACTAATGTAAAATGATTTCTAGTGGGAACATTT ATATTTTTATAATAAACATAATGAAAATATTTTTACAGATCAGAATAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
NM_010140 ⟹ NP_034270
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Mouse Assembly Chr Position (strand) Source GRCm39 16 63,363,895 - 63,684,538 (-) NCBI GRCm38 16 63,543,532 - 63,864,175 (-) NCBI MGSCv37 16 63,545,044 - 63,863,983 (-) RGD Celera 16 63,844,890 - 64,154,791 (-) RGD cM Map 16 ENTREZGENE
Sequence:
AGTGTCAAACTTGACATCAGACTGCGAGCGGAGCATGGTAACTTCTCCAGCAATCAGAGCGCTC CCCCTCACATCAGTGGTATGCTTCGCGGAGATATGCTCCTCTCACTGCCCGGTGCACCAGCAACATGGATTGTCACCTCTCCATCCTCGTCCTGCTCGGCTGCTGCGTCCTCAGCTGCTCCGGAGAAC TGAGCCCACAGCCTTCCAACGAAGTTAATCTACTAGATTCGAAAACAATTCAAGGAGAGCTGGGCTGGATCTCCTACCCATCCCATGGGTGGGAAGAGATCAGTGGTGTTGATGAACATTACACACCA ATCAGGACTTACCAGGTGTGCAATGTCATGGATCACAGCCAAAATAATTGGCTGAGGACAAACTGGGTACCCAGAAACTCAGCTCAGAAGATCTATGTGGAGCTAAAGTTCACACTGCGGGACTGTAA CAGCATTCCATTGGTTTTGGGGACTTGCAAGGAGACCTTTAACCTGTACTACATGGAGTCTGATGATGATCATGGCGTCAAATTCCGAGAGCATCAGTTCACGAAGATTGACACCATTGCCGCTGATG AAAGTTTCACTCAGATGGATCTCGGGGATCGCATTCTGAAACTCAACACTGAGATTAGAGAAGTGGGACCAGTCAACAAAAAGGGGTTTTATTTGGCCTTTCAAGATGTTGGTGCTTGTGTTGCCTTG GTGTCTGTGAGAGTGTACTTCAAAAAGTGCCCGTTTACAGTGAAGAATCTGGCTATGTTTCCAGACACAGTGCCCATGGACTCCCAGTCTTTGGTGGAGGTTAGGGGCTCTTGTGTCAATAATTCCAA AGAGGAGGACCCTCCCAGGATGTACTGCAGCACAGAAGGGGAATGGCTGGTCCCCATTGGCAAATGCACTTGCAATGCTGGGTATGAAGAACGAGGTTTCATATGCCAAGCTTGTCGACCAGGCTTCT ACAAGGCTTCCGATGGTGCTGCTAAGTGTGCTAAGTGCCCACCACACAGCTCAACACAAGAAGATGGTTCAATGAACTGCAGGTGTGAGAATAATTATTTCCGGGCAGAAAAAGACCCTCCATCCATG GCTTGTACCCGACCTCCATCCGCACCAAGAAATGTTATCTCAAACATAAACGAGACCTCGGTTATCCTGGACTGGAGTTGGCCCCTGGACACAGGAGGCCGGAAGGATATTACCTTCAACATCATATG TAAAAAGTGTGGGTGGAATGTCAGGCAGTGTGAGCCGTGCAGCCCCAACGTCCGCTTCCTTCCTCGGCAGCTTGGACTCACCAACACCACGGTGACAGTGACAGACCTCCTAGCTCACACCAACTACA CCTTTGAGATCGATGCTGTTAATGGGGTGTCAGAGCTGAGCTCGCCACCGAGACAGTATGCCGCAGTCAGCATCACAACTAATCAGGCTGCTCCATCACCAGTTATGACAATTAAGAAAGATCGGACT TCCAGAAACAGTATCTCTTTATCTTGGCAAGAACCGGAACATCCAAATGGAATTATCCTGGACTATGAGGTCAAATACTATGAAAAGCAGGAGCAAGAGACGAGTTATACCATTTTGAGAGCAAGAGG CACAAATGTTACTATCAGTAGCCTCAAGCCAGATACTACTTATGTCTTCCAAATCCGAGCTCGGACAGCAGCGGGATATGGAACCAACAGCCGCAAATTTGAATTTGAAACTAGCCCAGACTCTTTCT CCATCTCCGGTGAAAACAGTCATGTGGTGATGATTGCTATTTCCGCAGCTGTGGCCATCATTGTCCTCACGGTGGTCACCTATGTTCTGGTCGGGAGGTTTTGTGGCTATCACAAGTCAAAACACAGT GCAGAGGAGAAGCGCCTTCACTTTGGGAATGGCCACTTAAAACTTCCAGGTCTCAGGACCTATGTTGATCCACATACATATGAAGACCCTACTCAAGCAGTTCATGAGTTCGCGAAGGAGTTGGATGC CACCAATATATCCATCGACAAAGTTGTTGGAGCAGGTGAATTTGGAGAAGTTTGCAGCGGCCGCTTAAAACTTCCTTCAAAAAAAGAGATTTCGGTGGCCATAAAGACCCTGAAAGTAGGGTATACCG AGAAACAGAGGAGAGACTTCCTCGGTGAAGCGAGCATCATGGGACAGTTTGACCATCCCAACATCATCCGACTGGAAGGCGTTGTCACTAAGAGTAAGCCAGTGATGATTGTCACGGAATACATGGAG AATGGCTCCTTGGACAGTTTCTTACGTAAGCACGATGCCCAGTTCACAGTCATCCAGCTTGTGGGAATGCTCCGTGGGATAGCATCAGGTATGAAATACCTCTCAGATATGGGCTACGTCCACCGGGA CCTTGCTGCTCGCAACATCTTGATCAACAGTAACTTAGTGTGTAAAGTTTCTGACTTTGGACTCTCTCGGGTACTTGAAGATGACCCAGAAGCTGCTTACACAACCAGGGGAGGAAAGATACCAATAA GGTGGACATCACCAGAAGCAATTGCCTACCGCAAGTTCACCTCAGCCAGCGATGTATGGAGTTACGGGATTGTTCTCTGGGAAGTGATGTCTTACGGAGAAAGGCCATACTGGGAGATGTCCAATCAG GATGTAATTAAGGCTGTGGATGAGGGCTATCGCCTGCCACCTCCCATGGATTGCCCAGCTGCCTTGTATCAGTTGATGTTGGACTGCTGGCAGAAAGACAGGAACAACAGACCCAAGTTCGAGCAGAT CGTCAGCATTCTGGACAAACTCATCCGGAATCCAGGCAGTCTGAAGATCATCACCAGCGCGGCTGCAAGGCCATCAAACCTTCTTCTGGACCAAAGCAATGTCGATATCGCTACCTTCCACACAACTG GTGATTGGCTTAACGGCATGAGGACAGCACACTGTAAGGAAATCTTCACAGGCGTCGAATACAGCTCCTGTGACACCATTGCCAAGATCTCCACAGATGACATGAAAAAGGTTGGTGTCACTGTGGTT GGGCCACAGAAGAAGATCATCAGCACCATTAAAGCTCTAGAAACACAATCTAAGAATGGTCCAGTTCCAGTGTAAAGTCCTGGAGGGATGTGAGAAACGGGAAGATGCAGCAGCATCCTGCAGACAGA TGGAAATGATAAATAAGATGCTGCAGAAAGCTCCAAGTCTAATAAGACACTCAGTTATAAGTCCAAATGCCTTAAAATGGAATTGAAAAATCTCTTTATTTTCCCCTATCATTTTACAGATGGGTGGG TGGGTGCATTTTGCTTTGTAATTGCTTTTTAAATGTTAATTGATGGGGTTAGTTAAAATTCTTCAGTATGAAGTGGAAGAACTAGTGTAGAGCCATTGATCATTAACTATCATGGAAATAAACCAAGT AAACTAGCAAAACAGACCTGAAGGCTTTGTTGTGAATGGCCACAGAGGAAAAGACTTGTCGTATTTTTATACACAGAAAAAAATCTGTAACAGGTATTTTGTTTCTTTTAAAAACAAGCAAAATGGAG GCATTTATACCTCAAACTATCTGGCCATACTTACTACCTTATCACGTTAGTATTCTCTTTATCTGTTTGAAGCATATAGAGATAAAGTTTGTAGTTGTTTTAAATACTATACATTTTTAATTGTTACC TTCCTTAAGTAGACCATGTAAAAACACGTCTTAATTTGGGGGCAAGTGCGTATTTATTTTCTTTTGGATTTTTAAATTGTTTTATATTTATGCCTTGATGATTTAATTTGGGTTTTGTTACAGCCAAG TGCCAAATGCTATTGCAAATTGTCAGCAGTAAGAAACATGTTTAACTATACCCAGAGAATTATATGTTCTTTTCTACAACTGTTGAACAATCCACTTACATGTACCAACAAAATGAAATGCTTTCCCT GTTCCTACTGTCACCAAATCACTCACAGTCTGAATATCCCATTCATTTTTGTCTCTTCATTTATCAGTAAATGTATGCTCCTAATTTAGTGTAATATACTGGCTTGTATGTAATAGATTTTTACCAAG ATGTCATACCTTCCCTACTCTGGTGCTTAGAGGATATCAACTCCTTTCATTCATGAAAGAAGCTTGTTAGAACTCCTTAGATTTGCAAACTGGAAAGATCAAAATGAGGTTAAATGGTTACAGTAATT GACAGCAGCATATAGGTAAATGCATGAGCCAAAAAAAAAAAAAATGATAAGAAAGAAAAATTGCTTGTTTTGAAAAGTCTTAATATCATTGCTTAAACATGTAGAGAATGATGATAACTAAGCTACTC ATCTGCATCACTGGGGTGTACGTCAATTAATTGCACACTTTCATGATCAATATCAGGTATAACTATCTTTGAGTCTTCCACTTCAATGTACCTATTGTGAGTTAGGTGCATGATTAGAAGCCTTGGCC TTCTAAACATATTATTAAGCATAACATTTTTGAAAAAGCAACTCATCGAACCAATAAATCCACATCCACAGACAATGGAGGAATGAGATGTCTCATTATGGGGATGTAGTCTTGCTGTTCCGGAAAGG CCAATTGTAAGCATATTCTTGAATATTAAGAAGGATGTGCCTAACGGGCATCCTGATGATGACACATGCTGAAGCAATATTTTAGATTCTGGATTTTCTTGCTGATAGTATCATTCCATAGGATCAAG GGATGTGTGTGTCACAGAACAAGATGGTTCAAACAGTGCTGTACGAAATACGTCTCTATGCAAAAAGGGACACTAAAGAAATACAGCTTCCAATCATAGAGGCAGATTTCCAAATGTAATCTGTTGTA GGTTTAGTATACTAGAGCTTAGGTGAGTTCTTTCAGATGTGAAATTGTTTCCCAAATGTTGACAATACTCCGTATCATGCTGCTAGAATTTGTACTGAACTTATAAGAGCATGAATATTTTGGAAATG AGCTGATGAAACTAATAATAAATTTTATATGTCCTGAAAGCAGGTAGAAAAGACTCTAATCAAGTAATTTAAAATTTGGAATACCAGGTCAAAATTCAAATCCAGCATCTGAACCAATTCGCCTATGA CAGCATTGATTCTCTTAGGCAATATTCTGAACATGCTAAAAAAATGAATTTCAAAATAATTAGGTATTCAAAACTTGTTGAATCTGTTGCATTTATTTTGACTGAGAATTTTGTTTGAAATTAGAGGT GGTTTAAGCAGTATATTGCTTTTCATTTGTCAGTATTTTTCTATCTCACCGTTTATGGATTTCCTTTGCATAACCCCTTCCCTGTACATATGTAAACATAACAGTGTACGATTCTGGACTGGGGAGTA GAGGTACTAGATCGCTTATGGCCATCTCTTTGTACAGGAACTACATTGCCTTCCCATATCAATGAGGCTACCGCTCCCTTGCCATGTTATGTACCATATTACCTGATTTGTATCTTAAATTTGATTTA TAGATATTATTTATTTCTCGCAACACACCCAGTCTAGGCTGTACTGAGTATCTATCAAGCCATGTATAAATATGATATGATTGGCAGTATGTGTTTACTTTAAACTTGCATTTTAAAAACATGGTTCA TTTAGTTTATGTTGCACAATGTAGATGGCCTCTTACTAATGTAAAATGATTTCTAGTGGGAACATTTATATTTTTATAATAAACATAATGAAAATATTTTTACAGATCAGAATA
hide sequence
RefSeq Acc Id:
NP_034270 ⟸ NM_010140
- Peptide Label:
isoform 1 precursor
- UniProtKB:
Q8BRB1 (UniProtKB/TrEMBL), Q8C3U1 (UniProtKB/TrEMBL)
- Sequence:
MDCHLSILVLLGCCVLSCSGELSPQPSNEVNLLDSKTIQGELGWISYPSHGWEEISGVDEHYTPIRTYQVCNVMDHSQNNWLRTNWVPRNSAQKIYVELKFTLRDCNSIPLVLGTCKETFNLYYMESD DDHGVKFREHQFTKIDTIAADESFTQMDLGDRILKLNTEIREVGPVNKKGFYLAFQDVGACVALVSVRVYFKKCPFTVKNLAMFPDTVPMDSQSLVEVRGSCVNNSKEEDPPRMYCSTEGEWLVPIGK CTCNAGYEERGFICQACRPGFYKASDGAAKCAKCPPHSSTQEDGSMNCRCENNYFRAEKDPPSMACTRPPSAPRNVISNINETSVILDWSWPLDTGGRKDITFNIICKKCGWNVRQCEPCSPNVRFLP RQLGLTNTTVTVTDLLAHTNYTFEIDAVNGVSELSSPPRQYAAVSITTNQAAPSPVMTIKKDRTSRNSISLSWQEPEHPNGIILDYEVKYYEKQEQETSYTILRARGTNVTISSLKPDTTYVFQIRAR TAAGYGTNSRKFEFETSPDSFSISGENSHVVMIAISAAVAIIVLTVVTYVLVGRFCGYHKSKHSAEEKRLHFGNGHLKLPGLRTYVDPHTYEDPTQAVHEFAKELDATNISIDKVVGAGEFGEVCSGR LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAA ARPSNLLLDQSNVDIATFHTTGDWLNGMRTAHCKEIFTGVEYSSCDTIAKISTDDMKKVGVTVVGPQKKIISTIKALETQSKNGPVPV
hide sequence
RefSeq Acc Id:
NP_001349381 ⟸ NM_001362452
- Peptide Label:
isoform 2 precursor
- UniProtKB:
B7ZNN5 (UniProtKB/TrEMBL), Q8C3U1 (UniProtKB/TrEMBL)
Ensembl Acc Id:
ENSMUSP00000156331 ⟸ ENSMUST00000231270
Ensembl Acc Id:
ENSMUSP00000155890 ⟸ ENSMUST00000232461
Ensembl Acc Id:
ENSMUSP00000155946 ⟸ ENSMUST00000232049
Ensembl Acc Id:
ENSMUSP00000155997 ⟸ ENSMUST00000232654
Ensembl Acc Id:
ENSMUSP00000066554 ⟸ ENSMUST00000064405
RGD ID: 6827023
Promoter ID: MM_KWN:21372
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: Brain, MEF_B6
Transcripts: ENSMUST00000064405, UC007ZPZ.1
Position: Mouse Assembly Chr Position (strand) Source MGSCv36 16 63,863,686 - 63,864,186 (-) MPROMDB
RGD ID: 13674214
Promoter ID: EPDNEW_M21256
Type: initiation region
Name: Epha3_1
Description: Mus musculus Eph receptor A3 , mRNA.
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Mouse Assembly Chr Position (strand) Source GRCm38 16 63,864,175 - 63,864,235 EPDNEW